These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24429177)

  • 1. Current status of outcome measure development in vasculitis.
    Merkel PA; Aydin SZ; Boers M; Cornell C; Direskeneli H; Gebhart D; Hatemi G; Luqmani R; Matteson EL; Milman N; Robson J; Seo P; Tomasson G
    J Rheumatol; 2014 Mar; 41(3):593-8. PubMed ID: 24429177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.
    Aydin SZ; Direskeneli H; Sreih A; Alibaz-Oner F; Gul A; Kamali S; Hatemi G; Kermani T; Mackie SL; Mahr A; Meara A; Milman N; Nugent H; Robson J; Tomasson G; Merkel PA
    J Rheumatol; 2015 Dec; 42(12):2465-9. PubMed ID: 26077399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
    Merkel PA; Aydin SZ; Boers M; Direskeneli H; Herlyn K; Seo P; Suppiah R; Tomasson G; Luqmani RA
    J Rheumatol; 2011 Jul; 38(7):1480-6. PubMed ID: 21724720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.
    Robson JC; Milman N; Tomasson G; Dawson J; Cronholm PF; Kellom K; Shea J; Ashdown S; Boers M; Boonen A; Casey GC; Farrar JT; Gebhart D; Krischer J; Lanier G; McAlear CA; Peck J; Sreih AG; Tugwell PS; Luqmani RA; Merkel PA
    J Rheumatol; 2015 Nov; 42(11):2204-9. PubMed ID: 26329344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.
    Aydin SZ; Robson JC; Sreih AG; Hill C; Alibaz-Oner F; Mackie S; Beard S; Gul A; Hatemi G; Kermani TA; Mahr A; Meara A; Milman N; Shea B; Tómasson G; Tugwell P; Direskeneli H; Merkel PA
    J Rheumatol; 2019 Sep; 46(9):1198-1201. PubMed ID: 30877212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
    Merkel PA; Seo P; Aries P; Neogi T; Villa-Forte A; Boers M; Cuthbertson D; Felson DT; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer J; Mahr A; Matteson EL; Specks U; Luqmani R; Stone J; ;
    J Rheumatol; 2005 Dec; 32(12):2488-95. PubMed ID: 16331794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Robson JC; Tomasson G; Milman N; Ashdown S; Boonen A; Casey GC; Cronholm PF; Cuthbertson D; Dawson J; Direskeneli H; Easley E; Kermani TA; Farrar JT; Gebhart D; Lanier G; Luqmani RA; Mahr A; McAlear CA; Peck J; Shea B; Shea JA; Sreih AG; Tugwell PS; Merkel PA
    J Rheumatol; 2017 Oct; 44(10):1529-1535. PubMed ID: 28864650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.
    Sreih AG; Alibaz-Oner F; Kermani TA; Aydin SZ; Cronholm PF; Davis T; Easley E; Gul A; Mahr A; McAlear CA; Milman N; Robson JC; Tomasson G; Direskeneli H; Merkel PA
    J Rheumatol; 2017 Dec; 44(12):1933-1937. PubMed ID: 28864646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020.
    Quinn KA; Monti S; Christensen R; Jayne D; Langford CA; Lanier GE; Mahr A; Pagnoux C; Shea B; Tugwell P; Viðarsdóttir MB; Tomasson G; Merkel PA
    Semin Arthritis Rheum; 2021 Oct; 51(5):1134-1138. PubMed ID: 34274125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and Health.
    Milman N; Boonen A; Merkel PA; Tugwell P
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):255-63. PubMed ID: 25048363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
    Muratore F; Pazzola G; Soriano A; Pipitone N; Croci S; Bonacini M; Boiardi L; Salvarani C
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):244-260. PubMed ID: 28895041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis therapy refines vasculitis mechanistic classification.
    Torp CK; Brüner M; Keller KK; Brouwer E; Hauge EM; McGonagle D; Kragstrup TW
    Autoimmun Rev; 2021 Jun; 20(6):102829. PubMed ID: 33872767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
    Merkel PA; Herlyn K; Mahr AD; Neogi T; Seo P; Walsh M; Boers M; Luqmani R
    J Rheumatol; 2009 Oct; 36(10):2362-8. PubMed ID: 19820226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification and epidemiology of the vasculitides.
    Watts RA; Scott DG
    Baillieres Clin Rheumatol; 1997 May; 11(2):191-217. PubMed ID: 9220075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.
    Hatemi G; Ozguler Y; Direskeneli H; Mahr A; Gul A; Levi V; Aydin SZ; Mumcu G; Sertel-Berk O; Stevens RM; Yazici H; Merkel PA
    J Rheumatol; 2015 Dec; 42(12):2436-41. PubMed ID: 26373563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review.
    Monti S; Quinn KA; Christensen R; Jayne D; Langford C; Lanier GE; Mahr A; Pagnoux C; Viðarsdóttir MB; Merkel PA; Tomasson G
    Semin Arthritis Rheum; 2020 Dec; 50(6):1314-1325. PubMed ID: 33130459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.
    Hatemi G; Meara A; Ozguler Y; Direskeneli H; Mahr A; Easley E; Gurcan M; Davis T; Gul A; Yazici Y; Zottenberg K; Esatoglu SN; Erer B; Kamali S; Yazici H; Cronholm PF; Merkel PA
    J Rheumatol; 2017 Nov; 44(11):1750-1753. PubMed ID: 28365574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.
    Milman N; McConville E; Robson JC; Boonen A; Tugwell P; Wells GA; Chaudhuri D; Dawson J; Tomasson G; Ashdown S; Gebhart D; Lanier G; Peck J; McAlear CA; Kellom KS; Cronholm PF; Merkel PA
    J Rheumatol; 2019 Oct; 46(10):1415-1420. PubMed ID: 30709951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vasculitis.
    Lally L; Spiera RF
    Rheum Dis Clin North Am; 2015 May; 41(2):315-31. PubMed ID: 25836645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
    Sørensen SF; Slot O; Tvede N; Petersen J
    Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.